CLIFF (Cordlife Group) Total Liabilities: $76.65 Mil (As of Mar. 2026)

What is Cordlife Group Total Liabilities?

Cordlife Group CLIFF 33 Total Liabilities is $76.65 Mil as of Mar. 2026. GuruFocus rates CLIFF with a GF Score™ of 33/100 and a GF Value™ of $0.20 (Significantly Overvalued). The stock has 4 warning signs investors should review.

Cordlife Group's Total Liabilities for the quarter that ended in Mar. 2026 was $76.65 Mil.

Cordlife Group's quarterly Total Liabilities declined from Sep. 2025 ($75.72 Mil) to Dec. 2025 ($75.37 Mil) but then increased from Dec. 2025 ($75.37 Mil) to Mar. 2026 ($76.65 Mil).

Cordlife Group's annual Total Liabilities increased from Dec. 2023 ($69.67 Mil) to Dec. 2024 ($73.08 Mil) and increased from Dec. 2024 ($73.08 Mil) to Dec. 2025 ($75.37 Mil).

Cordlife Group Total Liabilities Related Terms

Cordlife Group Total Liabilities Historical Data

* Premium members only.

The historical data trend for Cordlife Group's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cordlife Group Total Liabilities Chart

Cordlife Group Annual Data

Trend

Jun15

Jun16

Jun17

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Total Liabilities

Get a 7-Day Free Trial

71.16

69.29

69.67

73.08

75.37

Cordlife Group Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Total Liabilities	Get a 7-Day Free Trial															0.00	74.49	75.72	75.37	76.65

33GF Score

Cordlife Group Ltd CLIFF

Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Cordlife Group Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Cordlife Group's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	22.419	+	(0.533	+	51.596
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0.82)
	=	75.37

Total Liabilities	=	Total Assets (A: Dec. 2025 )	-	Total Equity (A: Dec. 2025 )
	=	156.318	-	80.949
	=	75.37

Cordlife Group's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	24.359	+	(0.51	+	50.985
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0.82)
	=	76.65

Total Liabilities	=	Total Assets (Q: Mar. 2026 )	-	Total Equity (Q: Mar. 2026 )
	=	156.672	-	80.019
	=	76.65

Frequently Asked Questions Learn more about Total Liabilities →

What does a Total Liabilities of $76.65 Mil mean?

Cordlife Group (CLIFF) has a Total Liabilities of $76.65 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Cordlife Group and its competitors.

Is Cordlife Group's Total Liabilities too high?

Cordlife Group's current Total Liabilities is $76.65 Mil. Overall, Cordlife Group has a GF Score™ of 33/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.

How does Cordlife Group's Total Liabilities compare to TMO and DHR?

Cordlife Group's Total Liabilities of $76.65 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Total Liabilities for a Medical Diagnostics & Research company?

A good Total Liabilities depends on the Medical Diagnostics & Research industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Total Liabilities mean?

A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Cordlife Group and its competitors. Cordlife Group's current Total Liabilities is $76.65 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Cordlife Group stock overvalued right now?

Based on GuruFocus' analysis, Cordlife Group (CLIFF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.20, compared to a current price of $0.15 — trading 24.8% below its estimated fair value. The current Total Liabilities is $76.65 Mil. Cordlife Group's overall GF Score™ is 33/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Total Liabilities calculated?

Total Liabilities is calculated from a company's financial statements. For Cordlife Group (CLIFF), the current Total Liabilities is $76.65 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cordlife Group (CLIFF) Overvalued in 2026?

Based on GuruFocus' analysis, Cordlife Group stock appears to be undervalued. The current stock price of $0.15 is trading 24.8% below its estimated GF Value™ of $0.20. GuruFocus considers Cordlife Group to be Significantly Overvalued.

Key valuation signals for CLIFF:

Total Liabilities: $76.65 Mil
GF Value™: $0.20 vs. price of $0.15 (24.8% below fair value)
GF Score™: 33/100 with 4 warning signs

No single metric tells the full story. See the CLIFF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cordlife Group Business Description

Industry Healthcare Medical Diagnostics & Research

Comparable Companies SGX:505 SGX:1H3 SGX:1B1 SGX:8YY TMO DHR SHSE:603259 XSWX:LONN IDXX A WAT NTRA IQV ILMN MTD DGX LH GH MEDP XPAR:ERF

Other Exchanges P8A:Singapore

Address 1 Kim Seng Promenade, No. 15-01, Great World City East, Singapore, SGP, 237994

Website https://www.cordlife.com

Cordlife Group Ltd is a consumer healthcare company dedicated to safeguarding the well-being of mother and child. Along with its subsidiaries, the company is engaged in the provision of diagnostics and cord blood banking services, which involve the processing and storage of cord blood stem cells. The group has two reportable segments as follows: the Banking segment, which derives maximum revenue, comprises the collection, processing, and banking of biological materials; and the Diagnostics segment, which comprises diagnostics testing services. Geographically, the group generates maximum revenue from Hong Kong, and the rest from the Philippines, India, Malaysia, Singapore, and other regions.

33GF Score

Get the complete analysis for CLIFF

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.15

Price

$0.20

GF Value

View CLIFF Analysis

See Total Liabilities data for all stocks →